Tim Lammens

20PUBLICATIONS
78CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Genomics and transcriptomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 12, 2026
Exploring the Role of Macrophage Marker CD68 in Pediatric Acute Myeloid Leukemia.

|Feb 27, 2026
Decoding NOTCH1: From T-Cell Development Guardian to Driver of Pediatric T-Cell Lymphoblastic Lymphoma.

Fran Leijnen, Tim Lammens

|Feb 25, 2026
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitors.

Iris H Nelen, Soetkin Leys, Sarah-Lee Bekaert

|Sep 18, 2025
Prime-time for LncRNA signatures in acute myeloid leukemia?

Zhiyao Ren, Barbara De Moerloose, Tim Lammens

|Aug 14, 2025
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia.

Patrícia Amaral, Rhona Christie, Daisy O F Gresham

|May 28, 2025
HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia.

Jonas De Kesel, Igor Fijalkowski, Tim Pieters

Pageof 4

Frequent Collaborators

6 joint publications

Barbara De Moerloose

5 joint publications

Jolien Vanhooren

4 joint publications

Zhiyao Ren

4 joint publications

Charlotte Derpoorter